Mixed cryoglobulinemia (MC) cross-reactive idiotypes (CRI): Structural and clinical significance

HCV Infection and Cryoglobulinemia

Volumn 9788847017054, Issue , 2012, Pages 99-105

  Gorevic, Peter D ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84930797572     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-88-470-1705-4_12     Document Type: Chapter

References (36)

1. Agnello V, Elfahal M (2007) Cryoglobulin types and rheumatoid factors associated with clinical manifestations in patients with hepatitis C virus infection. Dig Liver Dis 39(Suppl 1): S25-S31
2. Sene D, Ghillani-Dalbin P, Thibault V, Guis L, Musset L, Duhaut P, Poynard T, Piette JC, Cacoub P (2004) Long-term course of mixed cryoglobulinemia in patients infected with hepatitis C virus. J Rheumatol 31:2199-2206
3. Gorevic PD, Frangione B (1991) Mixed cryoglobulinemia cross-reactive idiotypes: implications for the relationship of MC to rheumatic and lymphoproliferative diseases. Semin Hematol 28:79-94
4. Kipps TJ (2006) Immunoglobulin genes. In: Detrick B, Hamilton RG, Folds JD (eds) Manual of molecular & clinical laboratory immunology, 7th edn. ASM, Washington, DC, pp 56-68
5. Suleyman S, Thompson KM, Mageed RA, Natvig JB (2000) Molecular analysis of human immunoglobulin heavy chain variable region associated determinants recognized by anti-VH3 antibodies 7B4, B6 and D12. Scand J Immunol 52: 341-347
6. Potter KN, Li Y, Mageed RA, Jefferis R, Capra JD (1999) Molecular characterization of the VH1-specific variable region determinants recognized by anti-idiotypic monoclonal antibodies G6 and G8. Scand J Immunol 50:14-20
7. Sansonno D, Lauletta G, Nisi L, Fatti F, Pesola N, Pansini N, Dammaco F (2003) Non-enveloped HCV core protein as constitutive antigen of cold-precipitable immune complexes in type II mixed cryoglobulinemia. Clin Exp Immunol 133: 275-282
8. Shokri F, Mageed RA, Maziak BR, Talal N, Amos N, Williams BD, Jefferis R (2000) Lymphoproliferation in primary Sjogrens syndrome. Evidence of selective expansion of a B cell subset characterized by the expression of cross-reactive idiotypes. Arthritis Rheum 36:1128-1136
9. Fornasieri A, Bernasconi P, Ribero ML, Sinico RA, Fasola M, Zhou J, Portera G, Tagger A, Gibelli A, D'Amico GD (2000) Hepatitis C virus (HCV) in lymphocyte subsets and in B lymphocytes expressing rheumatoid factor cross-reacting idiotype in type II mixed cryoglobulinemia. Clin Exp Immunol 122:400-403
10. Sansonno D, Lauletta G, De Re V, Tucci FA, Gatti P, Racanelli V, Boiocchi M, Dammacco F (2004) Intrahepatic B-cell clonal expansions and extrahepatic manifestations of chronic HCV infection. Eur J Immunol 34:126-136
11. Vallat L, Benhamou Y, Gutierrez M, Ghillani P, Hercher C, Thibault V, Charlotte F, Piette JC, Poynard T, Merle-Béral H, Davi F, Cacoub P (2004) Clonal B cell populations in the blood and liver of patients with chronic hepatitis C virus infection. Arthritis Rheum 50:3668-3678
12. Fazi C, Dagklis A, Cottini F, Scarfo L, Bertilaccio MTS, Finazzi R, Memoli M, Ghia P (2010) Monoclonal B cell lymphocytosis in hepatitis C virus infected individuals. Cytometry B Clin Cytom 78B(Suppl 1):S61-S68
13. Charles ED, Green RM, Marukian S, Talal AH, Lake-Bakaar GV, Jacobson IM, Rice CM, Dustin LB (2008) Clonal expansion of immunoglobulin M + CD27+ B cells in HCVassociated mixed cryoglobulinemia. Blood 111:1344-1356
14. Rosa D, Saletti G, De Gregorio E, Zorat F, Comar C, D'Oro U, Nuti S, Houghton M, Barnaba V, Pozzato G, Abrignani S (2005) Activation of naïve B lymphocytes via CD81, a pathogenetic mechanism for hepatitis c virus-associated B lymphocyte disorders. Proc Natl Acad Sci USA 102: 18544-18549
15. Carbonari M, Caprini E, Tedesco T, Mazzettta F, Tocco V, Casato M, Russo G, Fiorilli M (2005) Hepatitis C virus drives the unconstrained monoclonal expansion of VH1-69-expressing memory B cells in type II cryoglobulinemia: A model of infection-driven lymphomagenesis. J Immunol 174:6532-6539
16. Baimpa E, Dahabreh IJ, Voulgarelis M, Moutsopoulos HM (2009) Hematologic manifestations and predictors of lymphoma development in primary sjögren syndrome: clinical and pathophysiologic aspects. Medicine 88:284-293
17. De Re V, De Vita S, Gasparotto D, Marzotto A, Carbone A, Ferraccioli G, Boiocchi M (2002) Salivary gland B cell lymphoproliferative disorders in Sjögren's syndrome present a restricted use of antigen receptor gene segments similar to those used by hepatitis C virus-associated non-Hodgkins's lymphomas. Eur J Immunol 32:903-910
18. Dörner T, Hansen A, Jacobi A, Lipsky PE (2004) Immunglobulin repertoire analysis provides new insights into the immunopathogenesis of Sjögren's syndrome. Autoimmun Rev 1:119-124
19. Knight G, Gao L, Gragnani L, Elfahal MM, De Rosa FG, Gordon FD, Agnello V (2010) Detection of Wa B cells in hepatitis C virus infection. A potential prognostic marker for cryoglobulinemic vasculitis and B cell malignancies. Arthritis Rheum 62:2152-2159
20. Chan CH, Hadlock KG, Foung SK, Levy S (2001) VH1-69 Gene is preferentially used by hepatitis C virus-associated B cell lymphomas and by normal B-cells responding to the E2 viral antigen. Blood 97:1023-1026
21. Machida K, Cheng KT, Pavio N, Sung VM, Lai MM (2005) Hepatitis C virus E2-CD81 interaction induces hypermutation of the immunoglobulin gene in B cells. J Virol 79: 8079-8089
22. Casato M, Mecucci C, Agnello V, Fiorilli M, Knight GB, Matteucci C (2002) Regression of lymphoproliferative disorder after treatment for hepatitis C virus infection in a patient with partial trisomy 3, Bcl-2 overexpression and type II cryoglobulinemia. Blood 99:2259-2261
23. Ivanoski M, Silvestri F, Pozzato G, Anand S, Mazzaro C, Burrone OR, Efremov DG (1998) Somatic hypermutation, clonal diversity, and preferential expression of the VH51p1/ VL kv325 immunoglobulin gene combination in hepatitis C virus-associated immunocytomas. Blood 91:2433-2442
24. De Re V, De Vita S, Marzotto A, Rupolo M, Gloghini A, Pivetta B, Gasparotto D, Carbone A, Boiocchi M (2000) Sequence analysis of the immunoglobulin antigen receptor of hepatitis C virus-associated non-Hodgkin lymphomas suggests that the malignant cells are derived from the rheumatoid factor-producing cells that occur mainly in type II cryoglobulinemia. Blood 96:3578-3584
25. Marasca R, Vaccari P, Luppi M, Zucchini P, Castelli I, Barozzi P, Cuoghi A, Torelli G (2001) Immunoglobulin gene mutations and frequent use of VH1-69 and VH4-34 segments in hepatitis C virus-positive and hepatitis C virusnegative nodal marginal zone B-cell lymphoma. Am J Pathol 159:253-261
26. Smilevska T, Tsakou E, Hadzidimitriou A, Bikos V, Stavroyianni N, Laoutaris N, Fassas A, Agagnostopoulos A, Papadaki T, Belessi C, Stamatopoulos K (2008) Immunoglobulin kappa repertoire and somatic hypermutation patterns in follicular lymphoma blood cells. Blood Cells Mol Dis 41:215-218
27. Arcaini L, Bruno R (2010) Hepatitis C virus infection and antiviral treatment in marginal zone lymphomas. Curr Clin Pharmacol 5:74-81
28. Bende RJ, Aarts WM, Riedl RG, Daphne De Jong, Pals ST, van Noesel CJM (2005) Among B cell non-Hodgkins lymphomas, MALT lymphomas express a unique autoantibody repertoire with frequent rheumatoid factor reactivity. J Exp Med 201:1229-1241
29. Landau DA, Saadoun D, Halfon P, Martinot-Peignoux M, Marcellin P, Fois E, Cacoub P (2008) Relapse of hepatitis C virus-associated mixed cryoglobulinemia vasculitis in patients with sustained viral response. Arthritis Rheum 58:604-611
30. Dammacco F, Tucci FA, Lauletta G, Gatti P, De Re V, Conteduca V, Sansonno S, Russi S, Mariggiò MA, Chironna M, Sansonno D (2010) Pegylated interferon-{alpha}, ribavirin, and rituximab combined therapy of hepatitis C virusrelated mixed cryoglobulinemia: A long-term study. Blood 116:343-353
31. Saadoun D, Resche Rigon M, Sene D, Terrier B, Karras A, Perard L, Schoindre Y, Coppéré B, Blanc F, Musset L, Piette JC, Rosenzwajg M, Cacoub P (2010) Rituximab plus Peginterferon-alpha/ribavirin compared with Peg-interferonalpha/ ribavirin in hepatitis C-related mixed cryoglobulinemia. Blood 116:326-334
32. Terrier B, Sene D, Deechartres A, Saadoun D, Ortonne N, Rouvier P, Musset L, Rigon MR, Maisonobe T, Cacoub P (2011) Systemic vasculitis in patients with hepatitis C virus infection with and without detectable mixed cryoglobulinia. J Rheumatol 38:104-110
33. Ramsland PA, Movafagh BF, Reichlin M, Edmundson AB (1999) Interference of rheumatoid factor activity by aspartame, a dipeptide methyl ester. J Mol Recognit 12:249-257
34. Charles ED, Orloff MIM, Dustin LB (2011) Aflow cytometry-based strategy to identify andf express IgM from VH1-69+ clonal peripheral B cells. J Immunol Methods 363:210-220
35. Maeda M, Inaba S, Nomura A, Tokunaga Y, Sugio Y, Itoh Y, Iino T, Otsuka T, Okamura S, Niho Y (2000) Vaccination of a refractory essential monoclonal cryoglobulinemia patient with cryoglobulin-pulsed dendritic cells. Leuk Lymphoma 39:441-446
36. de Re V, Simula MP, Pavan A, Garziera M, Marin D, Dolcetti R, de Vita S, Sansonno D, Geremia S, Toffoli G (2009) Characterization of antibodies directed against the immunoglobulin light kappa chain variable chain region (VK) of hepatitis C virus-related type-II mixed cryoglobulinemia and B-cell proliferations. Ann N Y Acad Sci 1173: 152-160